Andreas Vente
Impact in
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis
- Antibiotics Pharmacokinetics and Efficacy
- Biotechnology top 10%
Papers in
- Pharmacology 21
- Microbial Natural Products and Biosynthesis 17
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Burkholderia infections and melioidosis 4
- Urinary Tract Infections Management 2
- Co-authors
- Andreas Bechthold (12 shared papers)Stefan Pelzer (8 shared papers)Andriy N. Luzhetskyy (7 shared papers)Wolfgang Wohlleben (2 shared papers)Tilmann Weber (2 shared papers)Katrin Welzel (4 shared papers)Daniel Krug (1 shared paper)Rolf Müller (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (8 papers)Frontiers in Microbiology (3 papers)Antibiotics (2 papers)ChemBioChem (2 papers)Journal of Biotechnology (2 papers)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Andreas Vente
33 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 67
- Pharmacology 741
- Biotechnology 53
- Molecular Medicine 46
- Applied Microbiology and Biotechnology 12
- Molecular Biology 251
Countries citing papers authored by Andreas Vente
This map shows the geographic impact of Andreas Vente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Vente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Vente more than expected).
Fields of papers citing papers by Andreas Vente
This network shows the impact of papers produced by Andreas Vente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Vente. The network helps show where Andreas Vente may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Vente, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 164 | |
| 2 | 2001 | 121 | |
| 3 | 2003 | 112 | |
| 4 | 2002 | 108 | |
| 5 | 2008 | 97 | |
| 6 | 2007 | 89 | |
| 7 | 2006 | 77 | |
| 8 | 2006 | 71 | |
| 9 | 2007 | 44 | |
| 10 | 2005 | 41 | |
| 11 | 2018 | 30 | |
| 12 | 2011 | 25 | |
| 13 | 2017 | 25 | |
| 14 | 1999 | 23 | |
| 15 | 2012 | 22 | |
| 16 | 2017 | 19 | |
| 17 | 2007 | 15 | |
| 18 | 2008 | 15 | |
| 19 | Novel natural compounds obtained by genome-based screening and genetic engineering. | 2005 | 14 |
| 20 | 2018 | 13 |
About Andreas Vente
Andreas Vente is a scholar working on Pharmacology, Epidemiology, Molecular Medicine, Molecular Biology and Parasitology, having authored 33 papers that have together received 1.2k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (17 papers), Burkholderia infections and melioidosis (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Plant Molecular Biology Research (2 papers), Carbohydrate Chemistry and Synthesis (2 papers), Urinary Tract Infections Management (2 papers), Enzyme Catalysis and Immobilization (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Pharmacology (741 citations), Biotechnology (53 citations), Molecular Medicine (46 citations), Applied Microbiology and Biotechnology (12 citations) and Molecular Biology (251 citations). Andreas Vente has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Andreas Bechthold, Stefan Pelzer, Andriy N. Luzhetskyy, Wolfgang Wohlleben, Tilmann Weber, Katrin Welzel, Daniel Krug, Rolf Müller, Axel C. Trefzer and Roderich D. Süßmuth. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Frontiers in Microbiology, Antibiotics, ChemBioChem and Journal of Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.